Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues
Joint Authors
Verdoia, Monica
Camaro, Cyril
Kedhi, Elvin
Marcolongo, Marco
Suryapranata, Harry
De Luca, Giuseppe
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-04-07
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
Conflicting results have been reported so far in pooled analyses and studies evaluating the optimum duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients.
However, randomized clinical trials dedicated to this specific setting of higher thrombotic risk patients have only recently been completed, pointing at the noninferiority of a shorter strategy as compared to the traditional 12-month DAPT, furthermore allowing to reduce the risk of major bleeding complications.
Therefore, a reconsideration of current clinical practice and guidelines should be certainly be advocated in light of the most recent updates, especially among ACS patients treated with percutaneous coronary intervention (PCI) and modern drug-eluting stents (DES).
Our aim was to provide a comprehensive review of the available evidence on the optimal DAPT duration in ACS patients.
American Psychological Association (APA)
Verdoia, Monica& Camaro, Cyril& Kedhi, Elvin& Marcolongo, Marco& Suryapranata, Harry& De Luca, Giuseppe. 2020. Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues. Cardiovascular Therapeutics،Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1138612
Modern Language Association (MLA)
Verdoia, Monica…[et al.]. Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues. Cardiovascular Therapeutics No. 2020 (2020), pp.1-12.
https://search.emarefa.net/detail/BIM-1138612
American Medical Association (AMA)
Verdoia, Monica& Camaro, Cyril& Kedhi, Elvin& Marcolongo, Marco& Suryapranata, Harry& De Luca, Giuseppe. Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues. Cardiovascular Therapeutics. 2020. Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1138612
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1138612